DFH Pharma, Inc.

Gaithersburg, MD

UEI
ZS2FYG92ALX3
CAGE
6TK65
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
19008 Oxcart Pl, Gaithersburg, MD 20886, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
IND-enabling development of HIV maturation inhibitors formulated for use as either oral or long-acting parenterally… R44AI155312 National Institute of Allergy and Infectious Diseases (NIH) $1,951,894
Preclinical development of 2ND generation HIV maturation inhibitors R42AI155312 National Institute of Allergy and Infectious Diseases (NIH) $1,791,836
Preclinical development of 2ND generation HIV maturation inhibitors R41GM132683 National Institute of General Medical Sciences (NIH) $171,475
Preparation and characterization of 2ND generation HIV-1 maturation inhibitor DRU R41AI108457 National Institutes of Health $186,374

Grant subawards

Prime recipient Prime award Amount Awarded
Oak Crest Institute Of Science Manufacture and delivery of investigational HIV maturation inhibitor compounds. R01AI154561 $183,000

Quick answers

Is DFH Pharma, Inc. registered in SAM.gov?

Yes. DFH Pharma, Inc.'s SAM.gov registration is active through May 22, 2027.

What is DFH Pharma, Inc.'s most recent federal award?

DFH Pharma, Inc.'s most recent federal grant award is IND-enabling development of HIV maturation inhibitors formulated for use as either oral or long-acting parenterally… (R44AI155312), from National Institute of Allergy and Infectious Diseases (NIH), on July 8, 2020.

On GovTribe

See DFH Pharma, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login